Autolus Therapeutics PLC banner

Autolus Therapeutics PLC
NASDAQ:AUTL

Watchlist Manager
Autolus Therapeutics PLC Logo
Autolus Therapeutics PLC
NASDAQ:AUTL
Watchlist
Price: 1.41 USD 2.17% Market Closed
Market Cap: $375.3m

Wall Street
Price Targets

AUTL Price Targets Summary
Autolus Therapeutics PLC

Wall Street analysts forecast AUTL stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AUTL is 8.89 USD with a low forecast of 5.05 USD and a high forecast of 13.65 USD.

Lowest
Price Target
5.05 USD
258% Upside
Average
Price Target
8.89 USD
531% Upside
Highest
Price Target
13.65 USD
868% Upside
Autolus Therapeutics PLC Competitors:
Price Targets
CDNA
CareDx Inc
40% Upside
MEDP
Medpace Holdings Inc
0% Upside
RLMD
Relmada Therapeutics Inc
109% Upside
SHLS
Shoals Technologies Group Inc
45% Upside

Revenue
Forecast

61% / Year
Past Growth
72% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss
61% / Year
Past Growth
72% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss

For the last 8 years the compound annual growth rate for Autolus Therapeutics PLC's revenue is 61%. The projected CAGR for the next 3 years is 72%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Beat

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-65%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-65%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is AUTL's stock price target?
Price Target
8.89 USD

According to Wall Street analysts, the average 1-year price target for AUTL is 8.89 USD with a low forecast of 5.05 USD and a high forecast of 13.65 USD.

What is Autolus Therapeutics PLC's Revenue forecast?
Projected CAGR
72%

For the last 8 years the compound annual growth rate for Autolus Therapeutics PLC's revenue is 61%. The projected CAGR for the next 3 years is 72%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett